Skip to main navigation Home Investors Stock Recent News Financials Events Governance Resources Investor Relations NASDAQ: ICLR $273.97 -7.56 (-2.69%) Data Provided by Refinitiv. Minimum 15 minutes delayed. Investor Information ICON is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. Our services can be implemented separately or as part of a comprehensive full service clinical programme that can help expedite the time it takes to bring a drug to market and monitor its performance and safety post approval. Share Price NASDAQ Price $273.97 Change -7.56 High $282.75 Data Provided by Refinitiv. Minimum 15 minutes delayed. VIEW DETAILS Recent News Nov 22, 2021 ICON Releases Environmental, Social and Governance Report view more Upcoming Events December 01, 2021 at 12:10 PM EST Evercore ISI HealthCONx Conference view more Investing in ICON Learn more about which Industry Analysts cover ICON and other investment information. view more Contact About ICON Results & Reports For Clients Therapeutics Services Insights Innovation ICON For Investigators Mediakit Volunteers Investors Jobs & Careers News & Events Press Releases Events ICON on Social Media LinkedIn Twitter Facebook Youtube © 2021 ICON plc Disclaimer Privacy Site Cookies This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information. Accept